Direct answer (40-60 words)
Most reputable U.S. telehealth platforms charge $179 to $299 per month for compounded semaglutide in 2026, including the medication, prescription, supplies, and shipping. FormBlends starts at $179 per month. Brand-name Ozempic runs $940 to $1,150 cash; brand-name Wegovy runs $1,300 to $1,500. The price gap reflects business-model differences, not active-ingredient differences.
Table of contents
- The 30-second answer
- The 2026 price range across reputable platforms
- What's typically included in monthly pricing
- What sometimes costs extra
- Cost comparison: compounded vs. brand-name (12-month and 18-month tables)
- Why compounded semaglutide costs less
- Compounded semaglutide vs. compounded tirzepatide pricing
- Insurance, HSA, and FSA coverage
- Hidden costs to watch for
- Red flags when a price seems too good to be true
- FAQ
The 2026 price range across reputable platforms
Compounded semaglutide pricing in 2026 has consolidated into a narrower band than in 2023. The market has matured. Suspicious low-price outliers have largely been pushed out either by FDA enforcement actions or by patient quality complaints. Suspicious high-price outliers still exist but face competitive pressure.
Get compounded semaglutide from $99/mo
Free provider review, personalized dosing, and ongoing support included.
Start Free Assessment →The current range:
- Low end: $179 to $199 per month for established platforms
- Mid range: $200 to $279 per month
- High end: $280 to $399 per month
- Outliers: under $150 (quality risk) or over $400 (excess markup)
The range is mostly a function of what's bundled. A $179 plan and a $299 plan from different platforms can be surprisingly similar in actual product, with the difference accounted for by add-on services (nutrition coaching, lab work, prescription delivery speed).
The price doesn't typically vary by dose. Whether you're at 0.25 mg or 2.4 mg weekly, the monthly cost is the same. This is because the marginal cost of higher concentrations is small for the compounding pharmacy, and it's simpler to bill flat-rate.
Pricing for a 4-week supply (one vial) at the most common concentrations:
- 2.5 mg/mL semaglutide: $179 to $299
- 5 mg/mL semaglutide: $199 to $329
- 10 mg/mL semaglutide: $229 to $399
The higher concentrations cost slightly more because they hold larger doses per vial, but the monthly subscription model usually evens this out.
What's typically included in monthly pricing
A standard compounded semaglutide subscription from a reputable platform includes:
- The medication itself. A 4-week supply at your prescribed dose.
- Initial telehealth consultation with a licensed provider. Usually 15 to 30 minutes via video or asynchronous chat.
- Prescription writing. A licensed clinician writes the prescription based on the consultation.
- Compounding by a state-licensed pharmacy. Most platforms partner with 503A or 503B pharmacies.
- Shipping. Cold-chain shipping to your home, usually 2 to 3 business days, sometimes overnight.
- Supplies. Most platforms include U-100 insulin syringes (typically 4 to 6 per month), alcohol wipes, and a sharps container.
- Ongoing access to the provider. For dose adjustment questions, side effect concerns, or other clinical issues.
- Refill management. Automatic monthly refills with a few days' lead time before shipment.
What's standard but not universal:
- Dose escalation without extra fees. Most include this; some charge per dose change.
- Pause/cancel without penalty. Most do; some charge restocking or cancellation fees.
- Lab work. Some platforms include basic labs (HbA1c, basic metabolic panel, lipids) at intake; many don't.
When comparing platforms, the price per month is less informative than the all-in cost over 6 or 12 months including any add-on fees.
What sometimes costs extra
The most common add-on fees, with typical ranges:
- Initial consultation: $0 to $150 (most include free; some charge separately)
- Lab work: $0 to $200 (where required by state or platform protocol)
- Expedited shipping: $20 to $40 (overnight upgrade)
- Dose adjustment consultation: $0 to $50 (when increasing or decreasing dose mid-cycle)
- Subscription cancellation: $0 to $100 (some platforms charge a one-time fee)
- Re-evaluation after a pause: $0 to $100 (after long pauses, some platforms require a new consultation)
- Provider messages outside the included visit: $0 to $30 per message (rare but exists)
- Replacement supplies for damaged vials: Typically free if reported within 24 hours
Some platforms publish all-in pricing with no add-on fees. Others publish a low base price and recover margin through add-ons. The latter usually costs more in practice.
When evaluating a platform, the most useful question to ask is: "What is my total cost over 6 months at maintenance dose, including all consultations, lab work, dose escalations, and supplies?" If the answer is significantly different from 6 times the advertised monthly price, the advertised price isn't the full picture.
Cost comparison: compounded vs. brand-name (12-month and 18-month tables)
Brand-name semaglutide is sold as Ozempic (for type 2 diabetes) or Wegovy (for chronic weight management). Pricing differs by indication.
Monthly cash prices (Q1 2026):
| Product | Cash price (no insurance) | With manufacturer savings card | Compounded equivalent |
|---|---|---|---|
| Ozempic 0.25/0.5 mg pen | $940 to $1,025 | As low as $25 (commercial insurance) | $179 to $299 |
| Ozempic 1 mg pen | $980 to $1,100 | As low as $25 | $179 to $299 |
| Ozempic 2 mg pen | $1,000 to $1,150 | As low as $25 | $179 to $299 |
| Wegovy (any dose) | $1,349 to $1,500 | Variable | $179 to $299 |
12-month total cost comparison:
| Scenario | Brand-name (cash) | Compounded ($199/mo) | Difference |
|---|---|---|---|
| Wegovy patient, no insurance | $16,188 | $2,388 | $13,800 |
| Ozempic patient, no insurance | $11,628 | $2,388 | $9,240 |
| Wegovy patient with employer insurance, $200 copay | $2,400 | $2,388 | $12 |
| Wegovy patient with insurance, $50 copay | $600 | $2,388 | -$1,788 |
| Ozempic patient with savings card, $25 copay | $300 | $2,388 | -$2,088 |
18-month total cost comparison (typical full-treatment course):
| Scenario | Brand-name (cash) | Compounded ($199/mo) | Difference |
|---|---|---|---|
| Wegovy patient, no insurance | $24,282 | $3,582 | $20,700 |
| Ozempic patient, no insurance | $17,442 | $3,582 | $13,860 |
| Patient with limited insurance coverage | $5,000 to $10,000+ | $3,582 | Often favors compounded |
The pattern is consistent. For uninsured patients or patients with high copays, compounded semaglutide is dramatically cheaper. For patients with strong insurance coverage and low copays (under $100/month), brand-name with insurance can be cheaper than compounded.
The decision is patient-specific. A licensed clinician can walk through the trade-offs.
For more on Walmart pricing specifically, see related guide.
Why compounded semaglutide costs less
Compounded semaglutide isn't generic semaglutide. There's no FDA-approved generic of semaglutide as of 2026. The active ingredient is the same molecule, but the regulatory and economic structure is different.
Several factors drive the price difference.
No patent premium. Novo Nordisk's patents on semaglutide extend into the early 2030s. During patent protection, brand-name pricing reflects what the market will bear, not the cost of production. Compounded versions don't carry this premium because the compounding pharmacy isn't reselling the patented product; it's compounding from the active ingredient (which is sourced from FDA-registered API suppliers).
No direct-to-consumer marketing. Brand-name manufacturers spend billions on television ads, physician education, sales reps, and patient support programs. Compounded medications are sold through telehealth platforms with much lower marketing spend per patient.
Direct-to-patient distribution. Brand-name medications go through wholesale distributors, retail pharmacies, and pharmacy benefit managers, each adding margin. Compounded medications go from the compounding pharmacy directly to the patient, eliminating those intermediaries.
Simpler packaging. Brand-name Ozempic comes in pre-filled multi-dose pens with sophisticated dose-counting mechanisms. Compounded semaglutide comes in standard pharmacy vials. The packaging difference accounts for some of the price difference.
No R&D cost recovery. Brand-name manufacturers price their products partly to recover the cost of clinical trials and development (semaglutide development cost an estimated $2 to $4 billion). Compounding pharmacies don't have this cost; they're using a molecule that's already been developed.
Lower regulatory overhead. Brand-name manufacturers maintain extensive post-marketing surveillance and FDA reporting infrastructure. Compounding pharmacies follow USP standards but have lower regulatory cost per dose.
The price difference doesn't reflect a difference in the active molecule. It reflects different business models, regulatory pathways, and distribution structures. The active ingredient is semaglutide in both cases.
Compounded semaglutide vs. compounded tirzepatide pricing
Compounded tirzepatide is more expensive than compounded semaglutide because the API itself costs more. Tirzepatide is a more complex molecule with a more constrained supply.
Typical 2026 pricing:
- Compounded semaglutide: $179 to $299 per month
- Compounded tirzepatide: $299 to $449 per month
The $100 to $150 monthly premium for tirzepatide reflects the API cost difference. Whether it's worth paying depends on your goals.
Efficacy comparison:
- Semaglutide (in STEP 1, Wegovy dose): 14.9% average body weight loss at 68 weeks
- Tirzepatide (in SURMOUNT-1, 15 mg dose): 20.9% average body weight loss at 72 weeks
Tirzepatide produces about 40% more weight loss on average, at about 50% higher monthly cost. The cost-per-pound math often favors tirzepatide despite the higher monthly fee.
For diabetes:
- Semaglutide (in SUSTAIN-6): about 1.0 to 1.6% A1C reduction
- Tirzepatide (in SURPASS): about 2.0 to 2.5% A1C reduction
The tirzepatide A1C effect is meaningfully larger.
The decision often comes down to: cost sensitivity, prior experience with semaglutide, side effect tolerance (tirzepatide tends to be slightly better tolerated for nausea but similar for other GI side effects), and provider judgment.
Insurance, HSA, and FSA coverage
Insurance coverage: Most U.S. insurance plans don't cover compounded medications. The coverage rules generally distinguish between FDA-approved medications (covered subject to formulary) and compounded medications (not covered).
The exception: a small number of progressive employer plans cover compounding pharmacy services as part of their pharmacy benefit. Check your plan documents or call your benefits department.
HSA and FSA eligibility: Compounded semaglutide is generally HSA/FSA-eligible because it's a prescribed medication. Most platforms accept HSA/FSA debit cards directly. Tax advantage of using HSA/FSA funds:
- Federal tax bracket 22%: about $44 saved per month on a $200 plan
- Federal tax bracket 32%: about $64 saved per month
- Plus state tax savings (varies)
The HSA/FSA tax savings effectively bring the $199/month price down to $135 to $155 after-tax for most patients.
The IRS rule: Section 213(d) of the IRS code allows medical expenses to be paid pre-tax via HSA or FSA when prescribed for a medical condition by a licensed provider. Compounded semaglutide qualifies. You'll typically receive a Letter of Medical Necessity from the platform if needed for FSA reimbursement.
Letters for FSA reimbursement: If your FSA administrator requires documentation, request a Letter of Medical Necessity from the prescribing platform. Most provide it on request at no cost.
Hidden costs to watch for
Beyond the headline monthly price, watch for:
Long minimum commitments. Some platforms require 3-month or 6-month commitments. If the medication doesn't suit you, you're locked in.
Auto-renewing annual subscriptions. A subscription that quietly renews for 12 more months can be costly to exit. Check the renewal terms.
"Free first month" trials with high subsequent pricing. A $99 first month followed by $349 monthly is more expensive over a year than a flat $199 plan.
Required add-on supplements. Some platforms bundle "required" GLP-1 support supplements. The supplements are usually optional and the bundling is a margin grab.
Dose escalation surcharges. Increasing from 0.5 mg to 1.0 mg typically shouldn't cost extra. If a platform charges $50 per dose change, the all-in cost is higher than advertised.
Lab fees deferred to a third party. A platform that requires labs but ships you to LabCorp at full retail charge ($100 to $200) without using your insurance is shifting cost away from the headline price.
State-specific surcharges. Some platforms have higher pricing in certain states due to additional regulatory requirements.
The simplest defense is to ask, in writing, for the all-in 6-month cost including all anticipated charges before signing up.
Red flags when a price seems too good to be true
Pricing under $150 per month for compounded semaglutide is unusual in 2026 and warrants scrutiny. Possible explanations:
1. The pharmacy isn't FDA-registered. Some operations are run from outside U.S. regulatory oversight or from pharmacies with quality concerns. The savings come from skipping the regulatory and quality infrastructure that legitimate platforms maintain.
2. The "semaglutide" isn't actually semaglutide. Independent testing has occasionally found products labeled as semaglutide that contain other GLP-1 agonists, are under-potent, or contain contaminants. This is a serious safety concern.
3. There's no real medical consultation. Some operations skip the licensed-provider step, which is a federal compliance issue and a safety issue.
4. The shipping isn't cold-chain. Semaglutide is temperature-sensitive. Inadequate shipping degrades potency.
5. The price is a teaser. The first month is cheap; the recurring price is hidden in the terms.
How to verify a platform is legitimate:
- The compounding pharmacy is named and FDA-registered (verify on the FDA website)
- A licensed prescribing provider is identifiable
- Independent reviews on Trustpilot, Google, or BBB are consistent and recent
- The terms of service are clearly published
- The platform responds to pre-purchase questions quickly and transparently
A reasonable price for legitimate compounded semaglutide in 2026 is $179 to $299. Anything outside that range deserves a closer look in either direction.
FAQ
How much does compounded semaglutide cost per month in 2026?
Most reputable platforms charge $179 to $299 per month, including medication, prescription, supplies, and shipping. FormBlends starts at $179.
Why is compounded semaglutide cheaper than Ozempic?
Compounded versions skip the patent premium, the brand-name marketing spend, the multi-tier distribution chain, the sophisticated pen packaging, and the R&D cost recovery built into brand-name pricing. The active ingredient is the same molecule.
Does insurance cover compounded semaglutide?
Usually not. Most insurance plans only cover FDA-approved medications. A small number of employer plans cover compounding pharmacy services. Use HSA/FSA funds for tax-advantaged payment.
Is compounded semaglutide as effective as Ozempic?
The active ingredient is the same molecule, so the pharmacology is the same. Compounded versions are not FDA-approved and aren't interchangeable with brand-name products in a regulatory sense, but the chemical compound performs the same way in the body when properly compounded.
Are there hidden fees on compounded semaglutide platforms?
Some platforms have add-on fees for consultations, dose changes, lab work, or expedited shipping. Ask for the all-in cost before signing up.
How long does a compounded semaglutide vial last?
Typically 4 weeks at your prescribed dose. The vial expiration after first puncture is usually 28 to 56 days, depending on the formulation.
Can I use HSA or FSA funds for compounded semaglutide?
Yes. Compounded semaglutide is HSA/FSA-eligible because it's a prescribed medication. The tax savings can effectively reduce the cost by 20 to 30%.
What's the difference in cost between compounded semaglutide and tirzepatide?
Tirzepatide typically costs $100 to $150 more per month than semaglutide because the API is more expensive. Tirzepatide also produces about 40% more weight loss on average, so the cost-per-pound math often favors tirzepatide.
Can I get a discount with a longer commitment?
Some platforms offer 5 to 20% discounts for prepaying 3, 6, or 12 months. Most patients benefit from staying on monthly billing for the first 1 to 3 months to confirm tolerance and effectiveness before committing.
What happens to my pricing if I need to escalate the dose?
Most platforms hold the price flat across dose escalations. Some charge for the dose-change consultation. Ask before signing up.
Are there cancellation fees?
Most reputable platforms allow free cancellation with 14 to 30 days' notice before the next billing cycle. Some require explicit cancellation requests; most allow easy online cancellation.
Is there a price difference between vial and pen-based compounded semaglutide?
Vial-based compounded semaglutide is the standard and cheapest format. Some platforms offer pre-filled syringes or pens for an additional $30 to $80 per month. The active ingredient and effect are the same.
Author / review note
Reviewed by the FormBlends Medical Team. References include the STEP 1 trial publication (Wilding et al., NEJM, 2021), the SURMOUNT-1 trial publication (Jastreboff et al., NEJM, 2022), the FDA's compounding compliance documents (current revision), and IRS Publication 502 on medical and dental expenses. Pricing data accessed Q1 2026 across major U.S. telehealth platforms.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →